IBRX- Immunitybio, Inc.

Name: Immunitybio, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Immunitybio, Inc. (IBRX) has 10 insiders with recent SEC Form 4 filings, including 9 buys and 11 sells. IBRX is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Other	Soon-Shiong Patrick	29.82M	$240.65M	-
CEO	Adcock Richard	548.2K	$4.42M	-
CFO	Sachs David C.	322.8K	$2.61M	-
Dir	Clark Wesley	162.8K	$1.31M	-
Dir	Cohen Cheryl	162.8K	$1.31M	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jun 5, 2023	Blaszyk Michael D	Director	Buy	71,915	$2.75	$198,023.35	+75.8%	-47.7%	+120.4%
Jun 2, 2023	Brennan John Owen	Director	Buy	25,000	$2.83	$70,700.00	+125.0%	-41.9%	+131.8%
Jun 1, 2023	Clark Wesley	Director	Buy	7,000	$2.91	$20,370.00	+700.0%	-43.9%	+118.4%
Oct 8, 2021	Adcock Richard	CEO &President	Buy	1,930	$8.81	$16,995.02	+27,571%	-29.2%	-41.9%
Aug 23, 2021	Cohen Cheryl77	Director	Sell	24,777	$10.07	$249,602.89	-5.6%	-43.9%	-64.1%
Aug 18, 2021	Cohen Cheryl77	Director	Sell	45,531	$10.12	$460,750.44	-9.1%	-24.4%	-53.6%
May 25, 2021	Simon Barry J.79	Director	Sell	125,000	$16.14	$2,018,056.87	-1.3%	-31.0%	-77.8%
Feb 5, 2021	Simon Barry J.79	See Remarks	Sale+OE	22,100	$23.09	$510,266.90	-0.7%	-	-
Feb 2, 2021	Simon Barry J.79	See Remarks	Sale+OE	82,070	$20.65	$1,694,802.95	-2.5%	-	-
Jan 28, 2021	Simon Barry J.79	See Remarks	Sale+OE	47,930	$20.59	$987,066.96	-0.8%	-	-

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC